Integrating autonomy in public health messaging by Katelyn Murphy, Devin Graham, Mark Faries

Get full text

Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study by Gregory A Daniels, Sigrun Hallmeyer, Mark Grose, Jon Richards, Mark Faries, Brendan D Curti, Kim A Margolin, Yiwei Zhang, Lynn Feun, Anlong Li, John R Hyngstrom, Robert H I Andtbacka

Get full text

Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run by Choongsung Yoo, Dante Xing, Drew E. Gonzalez, Victoria Jenkins, Kay Nottingham, Broderick Dickerson, Megan Leonard, Joungbo Ko, Megan H. Lewis, Mark Faries, Wesley Kephart, Martin Purpura, Ralf Jäger, Shawn D. Wells, Kylin Liao, Ryan Sowinski, Christopher J. Rasmussen, Richard B. Kreider

Get full text

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis by Timothy Vreeland, Diane Hale, Mark Faries, George E Peoples, Xianzhong Yu, Patrick McCarthy, Jessica Cindass, John Hyngstrom, James Jakub, Montaser F Shaheen, Guy Travis Clifton, Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, Anne E O’Shea, Robert Connor Chick, Franklin A Valdera, Ankur Tiwari, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Adam C Berger, Jeffrey J Sussman, Thomas E Wagner

Get full text